Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study timeline metadata was updated, with two date entries added and two removed, affecting milestone and update timestamps shown on the study record.
    Difference
    0.1%
    Check dated 2026-08-20T13:56:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision 3.6.5 has been added, replacing 3.6.4, indicating a minor update to the page's metadata/versioning rather than user-visible content.
    Difference
    0.0%
    Check dated 2026-08-13T11:41:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s revision history has been updated with new update dates (2026-07-30, 2028-03-01, 2026-07-02, 2026-07). Some older dates have been removed (2026-06-08, 2027-11-30, 2026-06-04, 2026-06).
    Difference
    0.1%
    Check dated 2026-08-06T09:40:03.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a content update to the study details page.
    Difference
    0.0%
    Check dated 2026-07-23T09:21:13.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.1 as the study document version. This appears to be an administrative update that does not modify core study content.
    Difference
    0.0%
    Check dated 2026-07-02T02:31:40.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.1, signaling a small build update. The study content and visible information remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-24T23:18:36.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.